Catalent Announces Lead Sponsorship of the 2010 Pharma Packaging & Labeling USA Conference
Somerset, NJ, May 11, 2010 — Catalent Pharma Solutions, a leading provider of outsourced clinical, commercial packaging and printing services to the global pharmaceutical and biotechnology industry, is proud to be the lead sponsor of the Pharma Packaging and Labeling USA Conference for the second consecutive year. The conference will be held on May 18 and 19, 2010 in Philadelphia.
Covering innovations in packaging materials, new technologies, anti-counterfeiting methods, compliance packaging, senior-friendly and child-resistant packaging and other important issues facing the pharmaceutical packaging and labeling industry today, the two-day conference is designed for top executives from leading U.S. pharmaceutical manufacturing companies, for the purposes of maximizing knowledge sharing and networking.
As the lead sponsor of the event, Catalent will have an active and integral role in the program, including opening and closing remarks from Victor Dixon, Vice President and General Manager of the Printed Components business of Catalent, and chairman of the conference.
Catalent will also host a cocktail reception at the close of day one of the conference and has also planned a workshop and post-conference visit to Catalent’s Moorestown, NJ facility on May 20th, the day following the event.
The on-site, interactive workshop will cover core technologies and solutions for quality and efficient printing, including a live demonstration of Catalent’s services, as well as other technology solutions, such as cutting-edge anti-counterfeiting, Media Enhanced Packaging with Watermark capabilities. The workshop will be presented by Victor Dixon and Brian McCarthy, Vice President of Business Development for Catalent’s Printed Components business.
Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 people at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion in annual revenue. For more information, visit www.catalent.com .